You are here

AusPAR: Sofosbuvir/velpatasvir

Australian Public Assessment Report

21 September 2021
AusPAR Details
AusPAR
Active Ingredient
Sofosbuvir/velpatasvir
Product Name
Epclusa
Sponsor
Gilead Sciences Pty Ltd
Submission Number
PM 2020-00171-1-2
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
26 August 2021
Publication Date

21 September 2021